Daniela Mercatelli

583 total citations
22 papers, 443 citations indexed

About

Daniela Mercatelli is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Daniela Mercatelli has authored 22 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 11 papers in Molecular Biology and 10 papers in Neurology. Recurrent topics in Daniela Mercatelli's work include Parkinson's Disease Mechanisms and Treatments (10 papers), Neuropeptides and Animal Physiology (9 papers) and Receptor Mechanisms and Signaling (8 papers). Daniela Mercatelli is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (10 papers), Neuropeptides and Animal Physiology (9 papers) and Receptor Mechanisms and Signaling (8 papers). Daniela Mercatelli collaborates with scholars based in Italy, United States and Switzerland. Daniela Mercatelli's co-authors include Michele Morari, Alberto Brugnoli, Ludovico Arcuri, Nurulain T. Zaveri, Salvatore Novello, Giovanna Paolone, Derya R. Shimshek, Luigi Bubacco, Lawrence Toll and Andrea Cippitelli and has published in prestigious journals such as Journal of Neuroscience, Scientific Reports and Pain.

In The Last Decade

Daniela Mercatelli

21 papers receiving 435 citations

Peers

Daniela Mercatelli
Danielle Sambo United States
Laura Montero United States
Molly M. Rajsombath United States
Yuen Yih Singapore
Daniela Mercatelli
Citations per year, relative to Daniela Mercatelli Daniela Mercatelli (= 1×) peers Pauline Wales

Countries citing papers authored by Daniela Mercatelli

Since Specialization
Citations

This map shows the geographic impact of Daniela Mercatelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Mercatelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Mercatelli more than expected).

Fields of papers citing papers by Daniela Mercatelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Mercatelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Mercatelli. The network helps show where Daniela Mercatelli may publish in the future.

Co-authorship network of co-authors of Daniela Mercatelli

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Mercatelli. A scholar is included among the top collaborators of Daniela Mercatelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Mercatelli. Daniela Mercatelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mercatelli, Daniela, Alberto Brugnoli, Anna Maio, et al.. (2025). Enhancement of D1 dopaminergic responses in aged LRRK2 G2019S knock-in mice. Neurobiology of Disease. 208. 106881–106881.
2.
Mercatelli, Daniela, et al.. (2022). Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice. Biomedicines. 10(4). 881–881. 7 indexed citations
3.
Presotto, Luca, Daniela Mercatelli, Maria Picchio, et al.. (2022). Development of a new toolbox for mouse PET–CT brain image analysis fully based on CT images and validation in a PD mouse model. Scientific Reports. 12(1). 15822–15822. 4 indexed citations
4.
Regoni, Maria, Stefano Comai, Daniela Mercatelli, et al.. (2021). Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse. Biomedicines. 9(5). 514–514. 4 indexed citations
5.
Mercatelli, Daniela, et al.. (2021). Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo. Neurobiology of Disease. 159. 105487–105487. 19 indexed citations
6.
Novello, Salvatore, Daniela Mercatelli, Alberto Brugnoli, et al.. (2021). In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity. Neurobiology of Disease. 162. 105579–105579. 10 indexed citations
7.
Mercatelli, Daniela, Alberto Brugnoli, Ilaria Morella, et al.. (2021). Regulator of G‐Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l‐Dopa‐induced dyskinesia. British Journal of Pharmacology. 180(7). 927–942. 2 indexed citations
8.
Regoni, Maria, Stefano Cattaneo, Daniela Mercatelli, et al.. (2020). Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity. Cell Death and Disease. 11(11). 963–963. 16 indexed citations
9.
Wyatt, Séan, Daniela Mercatelli, Michele Morari, et al.. (2019). Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling. Frontiers in Cell and Developmental Biology. 7. 191–191. 17 indexed citations
10.
Mercatelli, Daniela, et al.. (2019). Leucine‐rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes. Pharmacology Research & Perspectives. 7(3). e00484–e00484. 15 indexed citations
11.
Russo, Isabella, Giulietta Di Benedetto, Alice Kaganovich, et al.. (2018). Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4. Journal of Neuroinflammation. 15(1). 297–297. 36 indexed citations
12.
Mercatelli, Daniela, et al.. (2018). NOP Receptor Ligands and Parkinson’s Disease. Handbook of experimental pharmacology. 254. 213–232. 11 indexed citations
13.
Schoch, Jennifer J., et al.. (2018). Influence of neuropathic pain on nicotinic acetylcholine receptor plasticity and behavioral responses to nicotine in rats. Pain. 159(11). 2179–2191. 15 indexed citations
14.
Caputi, Francesca Felicia, et al.. (2018). Dynorphinergic system alterations in the corticostriatal circuitry of neuropathic mice support its role in the negative affective component of pain. Genes Brain & Behavior. 18(6). e12467–e12467. 28 indexed citations
15.
Longo, Francesco, Daniela Mercatelli, Salvatore Novello, et al.. (2017). Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice. Acta Neuropathologica Communications. 5(1). 22–22. 69 indexed citations
16.
Arcuri, Ludovico, Salvatore Novello, Daniela Mercatelli, et al.. (2017). Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists. British Journal of Pharmacology. 175(5). 782–796. 15 indexed citations
17.
Ozawa, Akihiko, Daniela Mercatelli, Jinhua Wu, et al.. (2015). Knock-In Mice with NOP-eGFP Receptors Identify Receptor Cellular and Regional Localization. Journal of Neuroscience. 35(33). 11682–11693. 53 indexed citations
18.
Paolone, Giovanna, Alberto Brugnoli, Ludovico Arcuri, Daniela Mercatelli, & Michele Morari. (2015). Eltoprazine prevents levodopa‐induced dyskinesias by reducing striatal glutamate and direct pathway activity. Movement Disorders. 30(13). 1728–1738. 52 indexed citations
19.
Cippitelli, Andrea, Jinhua Wu, Daniela Mercatelli, et al.. (2014). AT‐1001: a high‐affinity α3β4 nAChR ligand with novel nicotine‐suppressive pharmacology. British Journal of Pharmacology. 172(7). 1834–1845. 33 indexed citations
20.
Caputi, Francesca Felicia, Francesca Lattanzio, Donatella Carretta, et al.. (2013). Morphine and Fentanyl Differently Affect MOP and NOP Gene Expression in Human Neuroblastoma SH-SY5Y Cells. Journal of Molecular Neuroscience. 51(2). 532–538. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026